Evaluation of the Reasons and Consequences of Bleeding in Late Teens and Early Adulthood Patients With Severe Hemophilia A

Completed

Conditions studied: Hematologic Disease, Blood Coagulation Disorders

In brief

Understanding how often the bleeding events occur in the subjects who voluntarily decide to switch from prophylaxis to on-demand and in those subjects who remain on prophylaxis. Also look into the consequences of switching treatment in QoL (quality of life), development of target joints, activity level and reasons that might influence the desire to switch.

Key facts

Study ID
NCT00782470
Run by
Bayer
People needed
38
Starts
2007-12-01
Expected to finish
2010-11-01
Last updated by the study team
2014-11-03

Who can join

Age: 14 and older, up to 29. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.